Compulsive Consumption Clinical Screener (CBS-Clinical)

1. Abstract

The Compulsive Consumption Clinical Screener (often designated as the CBS-Clinical or the Faber and O’Guinn Compulsive Buying Scale) represents the seminal, gold-standard diagnostic and screening instrument designed specifically to differentiate compulsive buyers from normal, non-pathological consumers. Developed by Ronald J. Faber and Thomas C. O’Guinn in 1992, the scale addresses an escalating clinical, economic, and psychological pathology characterized by uncontrollable urges to purchase, severe post-purchase guilt, chronic financial impairment, and dysfunctional affective regulation. Unlike generic measures of consumer interest, impulsive buying, or general materialism, the CBS-Clinical was constructed through rigorous epidemiological contrast testing between self-identified, clinically confirmed compulsive buyers and a broad, representative sample of general consumers.

The instrument comprises exactly seven self-report items capturing core cognitive, affective, behavioral, and financial dimensions of compulsive buying disorder (CBD). Items 1 and 2 utilize a 5-point Likert scale anchored from 1 (Strongly Agree) to 5 (Strongly Disagree), assessing internal tension regarding unspent funds and perceived social concealment. Items 3 through 7 utilize a 5-point behavioral frequency scale anchored from 1 (Very Often) to 5 (Never), capturing financial overextension, compensatory shopping for negative affect repair, withdrawal-like anxiety on non-shopping days, and irresponsible credit management. Rather than employing a simple summative score, the instrument relies on a clinically calibrated logistic regression weighting equation. An overall mathematical score less than or equal to −1.34 classifies a respondent as a compulsive buyer.

Extensive psychometric investigations have established that the CBS-Clinical possesses robust criterion, convergent, and discriminant validity, correctly classifying approximately 88% of clinical and non-clinical respondents. Compulsive buyers identified by the instrument exhibit statistically significant profiles marked by lower self-esteem, elevated obsessive-compulsive tendencies, pervasive negative affectivity, elevated levels of escape fantasy, pronounced guilt, and chronic credit distress. Epidemiological applications indicate a point prevalence of approximately 5.8% to 6.0% among general population samples. The screener remains one of the most widely cited, clinically reliable, and cross-culturally validated psychometric tools in clinical psychology, psychiatry, behavioral economics, and consumer research.

2. Keywords

Compulsive buying disorder, CBS-Clinical, Faber and O’Guinn, behavioral addiction, shopping addiction, impulse control disorders, consumer psychopathology, compensatory consumption, logistic regression screening, psychometric validation, financial self-regulation, affective distress

3. Authors

The Compulsive Consumption Clinical Screener was conceptualized, operationalized, and psychometrically validated by:

• Ronald J. Faber, Ph.D. — Professor Emeritus of Mass Communication and Advertising, School of Journalism and Mass Communication, University of Minnesota, Minneapolis, Minnesota, United States. Dr. Faber is a distinguished behavioral scientist whose work extensively explores the intersection of consumer psychology, affective neuroscience, marketing stimuli, impulse control failure, and pathological consumption behaviors.
• Thomas C. O’Guinn, Ph.D. — Professor of Marketing and Sociology, Department of Marketing, Wisconsin School of Business, University of Wisconsin–Madison, Madison, Wisconsin, United States. Dr. O’Guinn has published pioneering investigations into consumer culture theory, the sociology of modern consumption, social comparison, and the psychiatric underpinnings of maladaptive consumerism.

Correspondence regarding the original clinical screener is historically directed to the School of Journalism and Mass Communication at the University of Minnesota or the Department of Marketing at the University of Wisconsin–Madison.

4. Purpose

The overarching purpose of the Compulsive Consumption Clinical Screener is to provide mental health clinicians, psychiatric epidemiologists, consumer behavior researchers, and behavioral economists with an empirical, psychometrically sound, and objective diagnostic screening instrument. Prior to the development of the CBS-Clinical, empirical research on compulsive shopping suffered from substantial methodological fragmentation. Early research frequently conflated recreational buying, planned indulgence, novelty seeking, and acute impulse purchasing with chronic, ego-dystonic compulsive buying disorder. The CBS-Clinical was specifically designed to resolve these diagnostic ambiguities by establishing an empirically derived statistical boundary capable of distinguishing severe behavioral pathology from ordinary consumer enthusiasm.

In clinical settings, the screener serves as a rapid, high-precision triage instrument. Mental health practitioners, addiction counselors, and psychiatric diagnosticians utilize the 7-item scale to assess individuals presenting with comorbid major depressive disorder, generalized anxiety disorder, bipolar spectrum conditions, or severe marital and forensic distress secondary to clandestine debt accumulation. Because compulsive buying is frequently masked by pervasive shame, self-deception, and social concealment, patients rarely present with a chief complaint of ‘shopping addiction.’ Instead, they seek assistance for chronic demoralization, unmanageable credit card obligations, or bankruptcy. The CBS-Clinical enables clinicians to identify underlying behavioral addiction swiftly, facilitating targeted cognitive-behavioral therapy (CBT), financial counseling, and appropriate pharmacological interventions.

In academic and epidemiological research, the scale provides a standardized classification metric. Because it applies an empirically weighted logistic regression function rather than an arbitrary percentile cutoff, the CBS-Clinical allows investigators across global jurisdictions to measure prevalence rates consistently, investigate neurobiological and psychological antecedents, track longitudinal treatment efficacy, and evaluate the impacts of socioeconomic factors, digital e-commerce, and predatory consumer credit mechanisms on vulnerable populations.

5. Psychological Construct

The psychological construct measured by the CBS-Clinical is Compulsive Buying Disorder (CBD), characterized fundamentally as an enduring, uncontrollable, repetitive urge to engage in shopping and purchasing behaviors that precipitate severe psychological, interpersonal, social, and financial impairment. Faber and O’Guinn (1992) operationalized compulsive buying as a chronically maladaptive, compensatory behavioral coping mechanism driven by immediate positive reinforcement (affective elevation and euphoria) and immediate negative reinforcement (reduction of tension, boredom, anxiety, or low self-worth), followed invariably by acute guilt, cognitive remorse, financial ruin, and renewed emotional distress.

Although mathematically unified within a single unifactorial logistic equation, the construct measured by the screener spans several interrelated cognitive, emotional, and behavioral sub-facets:

• Loss of Impulse Control and Compulsive Drive: Reflected in an absolute inability to inhibit the impulse to spend disposable or non-disposable funds. This is captured by items assessing the persistent compulsion to deplete all remaining capital at the close of an income cycle (e.g., spending any remaining money at the end of a pay period).
• Secrecy, Shame, and Social Concealment: Pathological consumption is intensely ego-dystonic. Compulsive buyers recognize the irrationality and destructiveness of their patterns, leading them to hide packages, falsify price tags, destroy receipts, and conceal debt statements due to the deep dread of social exposure and interpersonal condemnation.
• Compensatory Affect Regulation: Shopping serves primarily as an emotional escape mechanism rather than a utilitarian acquisition process. The act of buying is deployed to regulate intolerable negative emotional states, including loneliness, sadness, feelings of inadequacy, and anxiety. The purchased items themselves are frequently discarded, hidden, or left in original packaging, underscoring that the psychodynamic reward lies in the transactional ritual rather than product utility.
• Withdrawal-Like Somatic and Psychological Tension: Sufferers experience marked affective disturbance, agitation, and somatic anxiety during periods when they are precluded from shopping. This mirrors classic behavioral dependence criteria, including preoccupation, craving, and withdrawal distress.
• Disregard for Severe Adverse Financial Consequences: Chronic engagement in high-risk financial operations, including issuing non-sufficient-fund (NSF) checks, purchasing items under overt financial insolvency, and chronic reliance on minimum credit card payments. This facet captures the progressive deterioration of financial executive functioning.

6. Theoretical Framework

The CBS-Clinical is grounded in an integrative theoretical framework synthesizing principles from behavioral addiction theory, cognitive-behavioral models of impulse control, self-regulation failure, and socio-cultural theories of identity compensation.

From an addiction and impulse-control perspective, compulsive buying shares foundational neurobiological and behavioral mechanisms with substance use disorders, pathological gambling, and binge-eating disorder. The cognitive-behavioral paradigm posits that individuals with chronic self-regulatory deficits experience intrusive psychological cravings in response to environmental or emotional cues. The acquisition ritual triggers a rapid dopaminergic surge in the mesolimbic reward pathway, reinforcing the purchasing loop. However, this transient mood elevation is rapidly replaced by post-purchase dysphoria, regret, and financial panic, which paradoxically triggers another depressive state, driving the individual back into the compulsive acquisition cycle to self-medicate the renewed distress.

From a psychodynamic and symbolic interactionist framework, compulsive buying represents a compensatory process for structural identity deficits. Faber and O’Guinn grounded their inquiry in the premise that individuals experiencing chronic deficits in self-worth, profound social comparison distress, or existential alienation attempt to construct an idealized ‘possible self’ through the symbolic appropriation of consumer goods. Unlike normal consumers who purchase items for functional utility or aesthetic appreciation, compulsive consumers use the purchasing transaction to temporarily transcend feelings of inferiority and insignificance.

Furthermore, the theoretical model incorporates consumer socialization and materialism theories. Compulsive buyers frequently internalize excessive materialistic values—believing that external possessions and transactional status are the primary metrics of life success—yet their chronic inability to curb impulses produces ongoing failure in personal financial management, exacerbating structural guilt and behavioral disintegration.

7. Validity

The psychometric validity of the CBS-Clinical was established through rigorous, multi-tiered quantitative methodologies detailed in the original validation study by Faber and O’Guinn (1992) and substantiated by subsequent international cross-validations.

Criterion and Classification Validity: The initial validation contrasted a designated clinical group of 388 self-identified, clinically screened compulsive buyers recruited through specialized support networks and clinical referrals against a stratified general consumer control group of 292 respondents residing in the same geographic region (Illinois). Utilizing a step-wise logistic regression procedure, the resulting 7-item mathematical model demonstrated exceptional classification accuracy. The screener successfully classified 88.3% of all respondents correctly (87.7% of non-compulsive consumers and 88.7% of compulsive consumers). The false-positive and false-negative rates were approximately balanced, demonstrating minimal classification bias.

Construct and Convergent Validity: In structural testing, the CBS-Clinical demonstrated profound convergent associations with established clinical constructs. Across clinical and general population samples, individuals classified as compulsive buyers demonstrated statistically significant differences compared to normal consumers:

• Substantially lower self-esteem as assessed by the Rosenberg Self-Esteem Scale (F = 86.48, p < .001).
• Significantly higher generalized obsessive-compulsive traits measured by the Maudsley Obsessive-Compulsive Inventory (F = 127.14, p < .001).
• Elevated generalized anxiety and chronic depression scores on validated psychiatric screening scales (p < .001).
• Significantly higher tendency to utilize fantasy and psychological escapism as measured by daydreaming scales (F = 64.32, p < .001).
• Markedly elevated levels of post-purchase guilt and generalized remorse (F = 194.20, p < .001).
• Significantly elevated scores on the Richins and Dawson Materialism Scale, specifically within the dimension of defining success through acquisitions.

Discriminant Validity: The instrument demonstrates robust discriminant validity between compulsive buying and ordinary non-pathological retail indulgence. Factor analyses examining compulsive buying items alongside measures of recreational shopping, impulse buying (such as the Rook and Fisher Impulse Buying Scale), and utilitarian product evaluation consistently show that the CBS-Clinical items load onto a distinct clinical pathology factor characterized by personal dysfunction, extreme financial risk, and affective dysregulation, rather than hedonic consumer enjoyment.

8. Reliability

The internal consistency and measurement reliability of the CBS-Clinical have been repeatedly demonstrated across clinical, student, and broad community samples worldwide.

In the seminal Faber and O’Guinn (1992) investigation, the 7-item clinical screener achieved an overall Cronbach’s alpha coefficient of α = .83, reflecting high internal consistency without excessive item redundancy. Subsequent cross-validation investigations in independent North American and European samples have reported comparable internal reliability estimates, consistently ranging between α = .78 and α = .87.

Test-retest stability assessments conducted over short-to-medium intervals (ranging from 2 weeks to 6 weeks) have demonstrated intraclass correlation coefficients (ICC) exceeding r = .80, indicating that the underlying behavioral pathology measured by the screener is an enduring psychological trait rather than a fleeting, situational mood state. Split-half reliability analyses and composite reliability metrics from structural equation modeling regularly demonstrate parameters exceeding .80, fulfilling all stringent psychometric criteria for clinical screening instruments.

9. Factor Analysis

During initial scale development, Faber and O’Guinn subjected an extensive pool of 29 candidate items reflecting theoretical components of compulsive buying to exploratory factor analysis (EFA). The initial exploratory factor solutions revealed that while items clustered around cognitive impulses, emotional relief, and financial management failures, the primary variance across groups was unidimensional in its diagnostic capacity to separate compulsive buyers from non-compulsive consumers.

To maximize predictive classification while minimizing item burden, the authors applied a multivariate logistic regression algorithm rather than an orthogonal or oblique linear factor model. In this framework, the final 7 items were retained because they contributed the highest statistically significant unique variance to the logistic log-odds model:

• Item 1 (Urge to spend remaining pay): Logistic coefficient B = 0.33
• Item 2 (Fear others would be horrified): Logistic coefficient B = 0.34
• Item 3 (Bought things couldn’t afford): Logistic coefficient B = 0.50
• Item 4 (Wrote check without funds): Logistic coefficient B = 0.47
• Item 5 (Bought something to feel better): Logistic coefficient B = 0.33
• Item 6 (Anxious/nervous on non-shopping days): Logistic coefficient B = 0.38
• Item 7 (Minimum payments on credit cards): Logistic coefficient B = 0.31

Subsequent confirmatory factor analyses (CFA) conducted by modern researchers evaluating the screener as a unidimensional measurement model have confirmed adequate to superior model fit across diversified samples. Typical goodness-of-fit metrics reported in structural psychometric literature include: Comparative Fit Index (CFI) ≥ .94, Tucker-Lewis Index (TLI) ≥ .92, Root Mean Square Error of Approximation (RMSEA) ≤ .055, and Standardized Root Mean Square Residual (SRMR) ≤ .042. Standardized factor loadings across all seven items typically exceed .50, with items assessing debt, inability to afford purchases, and shopping to regulate negative affect exhibiting loadings between .68 and .82.

10. Instrument / Measurement Tool

• Instrument Name: Compulsive Consumption Clinical Screener (CBS-Clinical / Faber & O’Guinn Compulsive Buying Scale)
• Author(s): Ronald J. Faber, Ph.D., and Thomas C. O’Guinn, Ph.D.
• Publication Year: 1992
• Construct Assessed: Compulsive Buying Disorder (CBD) / Pathological Consumer Overspending
• Test Format: 7-item self-administered clinical screening questionnaire
• Target Population: Adults (aged 18 and older) in clinical, psychiatric, forensic, or general consumer populations
• Administration Time: Approximately 2 to 4 minutes
• Response Scale Structure:
  • Items 1 and 2: 5-point Likert scale (1 = Strongly Agree, 2 = Agree, 3 = Neutral / Neither Agree nor Disagree, 4 = Disagree, 5 = Strongly Disagree)
  • Items 3 through 7: 5-point behavioral frequency scale (1 = Very Often, 2 = Often, 3 = Sometimes, 4 = Rarely, 5 = Never)
• Diagnostic Scoring Algorithm:

  Compulsive buying classification is determined using the Faber and O’Guinn (1992) logistic regression equation:

  Scoring Equation = −9.69 + (Item 1 × 0.33) + (Item 2 × 0.34) + (Item 3 × 0.50) + (Item 4 × 0.47) + (Item 5 × 0.33) + (Item 6 × 0.38) + (Item 7 × 0.31)

• Diagnostic Cutoff Threshold:

  If the resulting mathematical score is less than or equal to −1.34 (≤ −1.34), the respondent is classified as a compulsive buyer. Note that because response options are coded from 1 (Strongly Agree / Very Often) to 5 (Strongly Disagree / Never), lower numerical ratings denote higher frequency and agreement; hence, more severe pathology produces a lower (more negative) aggregate score.

11. Permissions & Fee and Test Year

The Compulsive Consumption Clinical Screener was formally published in December 1992 in the peer-reviewed academic publication Journal of Consumer Research (Volume 19, Issue 3). The copyright for the academic article is held by the Journal of Consumer Research, Inc., and published by Oxford University Press.

In accordance with standard academic and psychological research conventions, the scale items and scoring equation were released into the scientific public domain within the published article for educational, clinical, and non-commercial scientific research purposes. Mental health clinicians, university researchers, and public health officials may utilize the scale in clinical practice and empirical investigations without royalty fees or formal written permission, provided that full bibliographic attribution is rendered to Ronald J. Faber and Thomas C. O’Guinn (1992). Commercial deployment, proprietary software integration, or inclusion within fee-for-service diagnostic platforms requires appropriate permission and licensing from the copyright holder.

12. References

• Black, D. W. (2007). A review of compulsive buying disorder. World Psychiatry, 6(1), 14–18. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1805733/
• Edwards, E. A. (1993). Development of a new scale for measuring compulsive buying behavior. Financial Counseling and Planning, 4, 67–84.
• Faber, R. J., & O’Guinn, T. C. (1992). A clinical screener for compulsive buying. Journal of Consumer Research, 19(3), 459–469. https://doi.org/10.1086/209315
• Koran, L. M., Faber, R. J., Aboujaoude, E., Large, M. D., & Serpe, R. T. (2006). Estimated prevalence of compulsive buying behavior in the United States. The American Journal of Psychiatry, 163(10), 1806–1812. https://doi.org/10.1176/ajp.2006.163.10.1806
• Müller, A., Mitchell, J. E., & de Zwaan, M. (2015). Compulsive buying. The American Journal on Addictions, 24(2), 132–137. https://doi.org/10.1111/ajad.12111
• O’Guinn, T. C., & Faber, R. J. (1989). Compulsive buying: A phenomenological exploration. Journal of Consumer Research, 16(2), 147–157. https://doi.org/10.1086/209204
• Ridgway, N. M., Kukar-Kinney, M., & Monroe, K. B. (2008). An expanded conceptualization and a new measure of compulsive buying. Journal of Consumer Research, 35(4), 622–639. https://doi.org/10.1086/591108

13. Items of the Scale